drugset / Trial / NCT00361283
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
Phase 4
Completed
108 enrolled
University of Florida
American College of Clinical Pharmacy · collabAmerican Heart Association · collab
NaSingle-groupOpen-labelScreening
Summary
The purpose of the study is to test whether atorvastatin (also known as Lipitor) has anti-inflammatory effects in people with no known heart disease or high cholesterol. We also are investigating whether or not genetic differences between people plays a role in the drug response.
Timeline
- Start
- 2004-06
- Primary completion
- 2008-12
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | Oral |
Indications
No indication recorded.